Health e News
Antiretroviral therapy (ART) adherence clubs, already operating in several high burden areas in Cape Town, have the potential to revolutionise the treatment of millions of HIV-positive South Africans and lighten the load on overburdened health workers.
- ///Our Health
Umgungundlovu ‘€“ A centre for children with special needs is being developed at the Qhamukile Primary School in the Umgungundlovu district of KwaZulu-Natal.
- ///Health
Smoking harms the brain by damaging learning, memory and reasoning, a new study published in the journal Age and Ageing says.
Government took a major step towards improving HIV treatment compliance and cost with the announcement that the new antiretroviral (ARV) tender will include a triple fixed dose combination (FDC) tablet, which combines three pills into one.
A number of organisations have expressed deep concern over the crisis in the Eastern Cape where patients are running out of lifesaving medication.
- ///News
At the opening of the SA HIV Clinicians Society there was an excellent debate on the stavudine (also known as d4T) 20mg trial. Francois Venter argued for and Eric Goemaere against. Dozens of Treatment Action Campaign members demonstrated against the trial and participated in the debate.
- ///Our Health
UMGUNGUNDLOVU. – Thabile* is a 19-year-old mother of two who gave birth to an HIV positive baby, Andiwe, two months ago.
- ///Health
CAPE TOWN – Tuberculosis transmission rates in South Africa and more specifically Cape Town have not changed at all over the past 100 years, even though people are living longer and being cured because of treatment. Many are cured, only to be infected again.
CAPE TOWN – After 30 years of HIV disease it is more important to deal with the costs of the medicines and how to sustain access to it, rather than treatment outcomes, according to an HIV specialist.
Cape Town ‘€“ Zero HIV infection rates will never be achieved unless tackling gender-based violence is part of addressing the epidemic, an expert told HIV specialists, researchers and nurses, meeting at the first Southern African HIV Clinicians Society conference.
- ///News
PRESS RELEASE:Bedaquiline is an anti-tuberculosis drug that is still being tested in clinical trials. It is not yet approved anywhere in the world, though it is steadily making progress towards approval in Europe and the United States.
- ///Health
Phamaceutical drug manufacturer, Novartis South Africa, has taken steps to make an important drug in the treatment of a rare type of leukaemia called chronic myelogenous leukaemia (CML), more accessible to patients who need it.